Recognizing the critical need for increased access to biomanufacturing, BioCanRx has focused support on bringing new facilities with sought after expertise online, onboarding new technology and facilitating knowledge transfer among facilities in an effort to provide affordable and sustainable access to biomanufacturing in Canada.
BioCanRx funded cores are able offer the research network expertise in biomanufacturing and other critical areas including commercialization and research program development. By providing operational funding and working in partnership with selected academic facilities, BioCanRx is able to guarantee network researchers access to the resources and expertise offered while also supporting each facility’s financial sustainability.
Funded Cores:
Point-of-care (POC) Facilities:
- Conconi Family Manufacturing Facility (Victoria)
- Cell Manufacturing Facility, Biotherapeutics Manufacturing Centre (Ottawa)
- Philip S Orsino Cell Therapy Facility (Toronto)
- Manitoba Centre for Advanced Cell and Tissue Therapy (Winnipeg)
Previously Funded Core and Biomanufacturing Facilities
Core Facilities:
- The Human Immune Testing Suite (HITS) (Hamilton)
- The Molecular & Cellular Immunology Core (MCIC) (Victoria)
Biomanufacturing Facilities:
- Virus Manufacturing Facility, Biotherapeutics Manufacturing Centre (Ottawa)
- Alberta Cell Therapy Manufacturing Centre (Edmonton)
BioCanRx Point-of-Care Committee
